https://doi.org/10.1186/s12935-020-01320-w
Y
Yanxiang Shao
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
557
Citations
14
h-index
19
i10-index
Yanxiang Shao is an academic researcher from Sichuan University. The author has contributed to research in topics: Bladder and Urothelial Cancer Treatments & Renal cell carcinoma treatment & Prostate Cancer Diagnosis and Treatment. The author has an h-index of 14, co-authored 51 publications.
ORCID: 0000-0003-3157-5440Papers by this author
worksPreoperative systemic immune-inflammation index predicts prognosis of patients with non-metastatic renal cell carcinoma: a propensity score-matched analysis
2020 · Cancer Cell International · 41 citations
Partial nephrectomy versus ablative therapies for cT1a renal masses: A Systematic Review and meta-analysis
2019 · European Journal of Surgical Oncology · 36 citations
https://doi.org/10.1016/j.ejso.2019.05.010
Risk factors for postoperative surgical complications after inguinal lymph node dissection in penile cancer patients
2025 · Scientific Reports · 1 citations
https://doi.org/10.1038/s41598-025-94047-5
Additional file 4 of Prognostic factors of non-muscle invasive bladder cancer: a study based on next-generation sequencing
2021 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.13533362
High preoperative serum alkaline phosphatase levels predict worse disease-free survival in patients with surgically treated non-metastatic renal cell carcinoma
2024 · Asian Journal of Surgery · 0 citations
https://doi.org/10.1016/j.asjsur.2024.11.073
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat